Drug Trial Radar · NCT04642924
SGM-101 in Locally Advanced and Recurrent Rectal Cancer
Last checked: Nov 19, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
203
Planned (sponsor's estimate)
Start
Oct 22, 2019
Primary completion
Oct 2021
Study completion Oct 2023
Sponsor
- Lead sponsor
- Leiden University Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Erasmus Medical Center; Amsterdam UMC, location VUmc; Catharina Ziekenhuis Eindhoven; Medical Center Haaglanden; Surgimab; Quest Medical Imaging; Centre for Human Drug Research, Netherlands
- First posted
- Nov 24, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Near-infrared fluorescence-guided oncologic surgery (EGOS) with the use of a tumor specific tracer (SGM-101) developed by Surgimab can provide valuable intra-operative information about tumor location and extensiveness, which can be difficult to detect with conventional visual and tactile feedback. Hence, this information could aid in intra-operative decision making and therewith foster complete resection margins and less extensive surgery. Subsequently, this may drastically improve patient care by improving oncologic outcome.
Conditions
- Rectal Cancer
- Recurrent Rectal Cancer
Interventions
SGM-101Drug
Fluorescence-guided surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Resection statusTime frame: 10 days post surgery
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Amsterdam University Medical Center
Amsterdam, Netherlands · Recruiting
Catharina Hospital Eindhoven
Eindhoven, Netherlands · Recruiting
Erasmus Medical Center
Rotterdam, Netherlands · Recruiting
Haaglanden Medisch Centrum
The Hague, Netherlands · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.